ArticleSeminars in dialysis

Risk of Serious Adverse Events and Death With Low-Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving Dialysis.

Flory T Muanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.